Cargando…

Enhanced Cytotoxicity on Cancer Cells by Combinational Treatment of PARP Inhibitor and 5-Azadeoxycytidine Accompanying Distinct Transcriptional Profiles

SIMPLE SUMMARY: We investigated the effect of combinational use of PARP inhibitors on cytotoxicity of 5-aza-dC in human cancer cell lines. The combinational treatment of 5-aza-dC and PARP inhibitor PJ-34 exhibited a stronger cytotoxicity compared with their treatment alone in blood cancer HL-60, U93...

Descripción completa

Detalles Bibliográficos
Autores principales:	Araki, Tomonori, Hamada, Kensuke, Myat, Aung Bhone, Ogino, Hideki, Hayashi, Kohei, Maeda, Miho, Tong, Ying, Murakami, Yasufumi, Nakao, Kazuhiko, Masutani, Mitsuko
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	MDPI 2022
Materias:	Article
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9454563/ https://www.ncbi.nlm.nih.gov/pubmed/36077707 http://dx.doi.org/10.3390/cancers14174171

Ejemplares similares

Loss of Parp-1 affects gene expression profile in a genome-wide manner in ES cells and liver cells
por: Ogino, Hideki, et al.
Publicado: (2007)

Loss of Parp-1 affects gene expression profile in a genome-wide manner in ES cells and liver cells
por: Ogino, Hideki, et al.
Publicado: (2007)

Radiosensitization to γ-Ray by Functional Inhibition of APOBEC3G
por: Tong, Ying, et al.
Publicado: (2022)

Spontaneous Development of Dental Dysplasia in Aged Parp-1 Knockout Mice
por: Fujihara, Hisako, et al.
Publicado: (2019)

ADP-ribosyltransferases Parp1 and Parp7 safeguard pluripotency of ES cells
por: Roper, Stephen J., et al.
Publicado: (2014)

Dabigatran‐induced esophagitis with full circumferential blue pigmentation
por: Araki, Tomonori, et al.
Publicado: (2023)

Impairment in S-phase entry of splenocytes of Parp-1 knockout mice
por: Watanabe, Fumiaki, et al.
Publicado: (2004)

Synergetic Effects of PARP Inhibitor AZD2281 and Cisplatin in Oral Squamous Cell Carcinoma in Vitro and in Vivo
por: Yasukawa, Masaaki, et al.
Publicado: (2016)

PARP Inhibitor PJ34 Suppresses Osteogenic Differentiation in Mouse Mesenchymal Stem Cells by Modulating BMP-2 Signaling Pathway
por: Kishi, Yuta, et al.
Publicado: (2015)

Loss of CtIP disturbs homologous recombination repair and sensitizes breast cancer cells to PARP inhibitors
por: Wang, Junhui, et al.
Publicado: (2015)

Stability of centrosome numbers in poly(ADP-ribose) polymerase-1- and poly(ADP-ribose) glycohydrolase-deficient mouse ES cells
por: Ogino, Hideki, et al.
Publicado: (2004)

PARP Inhibitor Decreases Akt Phosphorylation and Induces Centrosome Amplification and Chromosomal Aneuploidy in CHO-K1 Cells
por: Tanaka, Masakazu, et al.
Publicado: (2022)

XRCC1 counteracts poly(ADP ribose)polymerase (PARP) poisons, olaparib and talazoparib, and a clinical alkylating agent, temozolomide, by promoting the removal of trapped PARP1 from broken DNA
por: Hirota, Kouji, et al.
Publicado: (2022)

Reduced Tumorigenicity of Mouse ES Cells and the Augmented Anti-Tumor Therapeutic Effects under Parg Deficiency
por: Sonoda, Yuki, et al.
Publicado: (2020)

Erratum to “Impairment in S-phase entry of splenocytes of Parp-1 knockout mice”: [Proc. Jpn. Acad., Ser. B 79, No. 8, 248–251 (2003)]
por: Watanabe, Fumiaki, et al.
Publicado: (2004)

PolyADP-Ribosylation Is Required for Pronuclear Fusion during Postfertilization in Mice
por: Osada, Tomoharu, et al.
Publicado: (2010)

A comprehensive analysis of radiosensitization targets; functional inhibition of DNA methyltransferase 3B radiosensitizes by disrupting DNA damage regulation
por: Fujimori, Hiroaki, et al.
Publicado: (2015)

Congenital Prepubic Sinus Accompanied by Prevesical Abscess
por: Kobayashi, Hideki, et al.
Publicado: (2015)

Octreotide-Treated Diabetes Accompanied by Endogenous Hyperinsulinemic Hypoglycemia and Protein-Losing Gastroenteropathy
por: Takahashi, Nobuhiko, et al.
Publicado: (2011)

Serous retinal detachment accompanied by pachychoroid in hypotony maculopathy after trabeculectomy for diabetic neovascular glaucoma
por: Shimokawa, Sakurako, et al.
Publicado: (2020)

Normal brain imaging accompanies neuroimmunologically justified, autoimmune encephalomyelitis
por: Takewaki, Daiki, et al.
Publicado: (2018)

ADP-Ribosylation as Post-Translational Modification of Proteins: Use of Inhibitors in Cancer Control
por: Poltronieri, Palmiro, et al.
Publicado: (2021)

Early recruitment of PARP-dependent m(8)A RNA methylation at DNA lesions is subsequently accompanied by active DNA demethylation
por: Legartová, Soňa, et al.
Publicado: (2022)

Primary pleural lymphoma accompanied by silicosis
por: Matano, Yoshiki, et al.
Publicado: (2023)

Possible Action of Olaparib for Preventing Invasion of Oral Squamous Cell Carcinoma In Vitro and In Vivo
por: Nakamura, Nanami, et al.
Publicado: (2022)

Extracellular Release of HMGB1 as an Early Potential Biomarker for the Therapeutic Response in a Xenograft Model of Boron Neutron Capture Therapy
por: Imamichi, Shoji, et al.
Publicado: (2022)

Correction: Imamichi et al. Extracellular Release of HMGB1 as an Early Potential Biomarker for the Therapeutic Response in a Xenograft Model of Boron Neutron Capture Therapy. Biology 2022, 11, 420
por: Imamichi, Shoji, et al.
Publicado: (2023)

Immunomodulatory Roles of PARP-1 and PARP-2: Impact on PARP-Centered Cancer Therapies
por: Yélamos, José, et al.
Publicado: (2020)

PARP Power: A Structural Perspective on PARP1, PARP2, and PARP3 in DNA Damage Repair and Nucleosome Remodelling
por: van Beek, Lotte, et al.
Publicado: (2021)

Adult‐onset Still’s disease accompanying noninfective endocarditis
por: Oka, Kosuke, et al.
Publicado: (2020)

Sparsely methylated mitochondrial cell free DNA released from cardiomyocytes contributes to systemic inflammatory response accompanied by atrial fibrillation
por: Yamazoe, Masahiro, et al.
Publicado: (2021)

Suppression of Gl Arrest and Enhancement of G2 Arrest by Inhibitors of Poly(ADP‐ribose) Polymerase: Possible Involvement of Poly(ADP‐ribosyl)ation in Cell Cycle Arrest Following γ‐Irradiation
por: Nozaki, Tadashige, et al.
Publicado: (1994)

Inhibition of Poly (ADP-Ribose) Glycohydrolase Accelerates Osteoblast Differentiation in Preosteoblastic MC3T3-E1 Cells
por: Sasaki, Yuka, et al.
Publicado: (2022)

PARP inhibitors trap PARP2 and alter the mode of recruitment of PARP2 at DNA damage sites
por: Lin, Xiaohui, et al.
Publicado: (2022)

PARP inhibitors
por: Anwar, Maheen, et al.
Publicado: (2015)

Are PARPs promiscuous?
por: Feijs, Karla L.H., et al.
Publicado: (2022)

Hamman’s Syndrome Accompanied by Diabetic Ketoacidosis; a Case Report
por: Yamashita, Koya, et al.
Publicado: (2022)

Experimental system for measurement of radiologists’ performance by visual search task
por: Maeda, Eriko, et al.
Publicado: (2013)

PARP1 in Carcinomas and PARP1 Inhibitors as Antineoplastic Drugs
por: Wang, Luyao, et al.
Publicado: (2017)

Interactions of PARP1 Inhibitors with PARP1-Nucleosome Complexes
por: Maluchenko, Natalya, et al.
Publicado: (2022)

Cannot write session to /tmp/vufind_sessions/sess_ldtaims15mosdua4gvpcr3o2bg